(JM test VN long text) Smoking is the leading preventable cause of death in the developed world and quickly becoming so in developing countries. Currently, there are between 5 and 6 million deaths yearly in the world, and this figure is expected to climb to 10 million by around 2025,” said Dr. Carolyn Dresler, associate director for Medical and Health Sciences in the Office of Science at the FDA Center for Tobacco Products Office, US. “If a smoker does not quit, then they have a 50 percent chanc
08 Aug 2024
byElaine Soliven
Adding pembrolizumab to standard chemotherapy resulted in a favourable overall survival (OS) benefit in patients with advanced or recurrent endometrial cancer compared with chemotherapy alone, regardless of mismatch repair (MMR) status, according to a key prespecified secondary analysis of the NRG-GY018 trial presented at the SGO 2024.
(JM test VN long text) Smoking is the leading preventable cause of death in the developed world and quickly becoming so in developing countries. Currently, there are between 5 and 6 million deaths yearly in the world, and this figure is expected to climb to 10 million by around 2025,” said Dr. Carolyn Dresler, associate director for Medical and Health Sciences in the Office of Science at the FDA Center for Tobacco Products Office, US. “If a smoker does not quit, then they have a 50 percent chanc
08 Aug 2024
![[JM test]Interventional oncology faces trials on road to guideline inclusion](https://sitmspst.blob.core.windows.net/images/articles/dr-yasuaki-arai-83a2a415-d2a2-46f4-92b2-427d8ff77e7f-square.jpg)
